A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer

NCT01036113 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
160
Enrollment
INDUSTRY
Sponsor class

Stopped Program suspended and divested

Conditions

Interventions

Sponsor

Enzon Pharmaceuticals, Inc.